Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT

BACKGROUND: Assessing the risk of serious adverse events (SAEs) during hypertension treatment is important for understanding the benefit‐harm trade‐offs of lower blood pressure goals. It is unknown whether high‐sensitivity cardiac troponin T (hs‐cTnT) and N‐terminal pro‐B‐type natriuretic peptide (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascher, Simon B., Scherzer, Rebecca, de Lemos, Jame A., Estrella, Michelle M., Jotwani, Vasantha K., Garimella, Pranav S., Bullen, Alexander L., Ambrosius, Walter T., Ballantyne, Christie M., Nambi, Vijay, Killeen, Anthony A., Ix, Joachim H., Shlipak, Michael G., Berry, Jarett D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075292/
https://www.ncbi.nlm.nih.gov/pubmed/35243872
http://dx.doi.org/10.1161/JAHA.121.023314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075292/
https://www.ncbi.nlm.nih.gov/pubmed/35243872
http://dx.doi.org/10.1161/JAHA.121.023314

Ejemplares similares